Interleukin-6 in Plaque Psoriasis and Its Possible Role in Disease Severity

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

November 1, 2023

Primary Completion Date

October 31, 2024

Study Completion Date

October 31, 2024

Conditions

Interleukin-6Plaque PsoriasisDisease Severity

Interventions

OTHER

Enzyme-linked immunosorbent assay (ELISA)

The enzyme-linked immunosorbent assay (ELISA) was utilized in order to determine the levels of IL-6 in the serum

Trial Locations (1)

Tanta University, Tanta

All Listed Sponsors

lead

Tanta University

OTHER

NCT07001904 - Interleukin-6 in Plaque Psoriasis and Its Possible Role in Disease Severity | Biotech Hunter | Biotech Hunter